К основному контенту

Arimidex

Arimidex

     * Generic Name: anastrozole
     * Brand Name: Arimidex


     * What is anastrozole (Arimidex)?
     * What are the possible side effects of anastrozole (Arimidex)?
     * What is the most important information I should know about
       anastrozole (Arimidex)?
     * What should I discuss with my healthcare provider before taking
       anastrozole (Arimidex)?
     * How should I take anastrozole (Arimidex)?
     * What happens if I miss a dose (Arimidex)?
     * What happens if I overdose (Arimidex)?
     * What should I avoid while taking anastrozole (Arimidex)?
     * What other drugs will affect anastrozole (Arimidex)?
     * Where can I get more information (Arimidex)?

What is anastrozole (Arimidex)?

   Anastrozole lowers estrogen levels in postmenopausal women,
   which may slow the growth of certain types of breast tumors that need
   estrogen to grow in the body.

   Anastrozole is used to treat breast cancer in postmenopausal women.
   It is often given to women whose cancer has progressed even after
   taking tamoxifen (Nolvadex, Soltamox).

   Anastrozole may also be used for purposes not listed in this medication
   guide.

What are the possible side effects of anastrozole (Arimidex)?

   Get emergency medical help if you have signs of an allergic reaction:
   hives; difficult breathing; swelling of your face, lips, tongue, or
   throat.

   Call your doctor at once if you have:
     * shortness of breath (even with mild exertion), swelling, rapid
       weight gain;
     * a bone fracture;
     * swollen glands;
     * liver problems--nausea, upper stomach pain, itching, tired feeling,
       loss of appetite, dark urine, clay-colored stools,
       jaundice (yellowing of the skin or eyes);
     * signs of a stroke--sudden numbness or weakness (especially on
       one side of the body), sudden severe headache, slurred speech,
       problems with vision or balance; or
     * severe skin reaction--fever, sore throat, swelling in your face
       or tongue, burning in your eyes, skin pain, followed by a red or
       purple skin rash that spreads (especially in the face or upper
       body) and causes blistering and peeling.

   Common side effects may include:
     * weakness, hot flashes;
     * numbness or tingly feeling in your skin;
     * swelling in your ankles or feet;
     * joint pain or stiffness, problems with your fingers while
       gripping;
     * sore throat, headache, back pain, bone pain;
     * depression, mood changes, sleep problems (insomnia);
     * high blood pressure (severe headache, blurred vision, pounding
       in your neck or ears);
     * nausea, vomiting; or
     * mild rash.

   This is not a complete list of side effects and others may occur. Call
   your doctor for medical advice about side effects. You may report side
   effects to FDA at 1-800-FDA-1088.

What is the most important information I should know about anastrozole
(Arimidex)?

   Anastrozole may not work as well if you take it together with estrogen
   medication (such as hormone replacement therapy, estrogen creams, or
   birth control pills, injections, implants, skin patches, and vaginal
   rings).

   Anastrozole may increase your risk of a stroke or blood clot.
   Call your doctor at once if you have sudden numbness or weakness,
   (especially on one side of the body), sudden severe headache, slurred
   speech, or problems with vision or balance.

   Arimidex Patient Information including How Should I Take
   Breast Cancer Diagnosis and Treatment

   Breast Cancer Slideshow
   RxList

   Take the Breast Cancer Quiz
   Breast Cancer Pictures Slideshow: 10 Things Young Women Should Know

   Breast Cancer Screening

What should I discuss with my healthcare provider before taking anastrozole
(Arimidex)?

   You should not use this medication if you are allergic to anastrozole,
   if you are breast-feeding a baby, or if you have not yet completed
   menopause. Anastrozole is not for use in men or children.

   To make sure anastrozole is safe for you, tell your doctor if you have:
     * heart disease;
     * circulation problems;
     * a history of stroke or blood clot;
     * severe liver disease;
     * high cholesterol; or
     * osteoporosis or low bone mineral density.

   Anastrozole can decrease bone mineral density, which may increase your
   risk of developing osteoporosis. Your bone mineral density may need to
   be tested before and during treatment with anastrozole.

   Although it is not likely that a postmenopausal woman would be
   pregnant, anastrozole could harm an unborn baby. Do not take this
   medicine if you are pregnant or may become pregnant. Use effective
   birth control if you are not past menopause, and tell your doctor right
   away if you become pregnant during treatment.

   It is not known whether anastrozole passes into breast milk or if it
   could harm a nursing baby. You should not breast-feed while you are
   using anastrozole.

   You may need to take a pregnancy test before using anastrozole, to
   make sure you are not pregnant.

How should I take anastrozole (Arimidex)?

   Anastrozole is usually taken once per day. Follow all directions on
   your prescription label. Do not take this medicine in larger or smaller
   amounts or for longer than recommended.

   You may take anastrozole with or without food.

   You may need to keep taking this medication for up to 5 years. Follow
   your doctor's instructions.

   Store at room temperature away from moisture and heat.

   Arimidex Patient Information including If I Miss a Dose
   Breast Cancer Diagnosis and Treatment

   Breast Cancer Slideshow
   RxList

   Take the Breast Cancer Quiz
   Breast Cancer Pictures Slideshow: 10 Things Young Women Should Know

   Breast Cancer Screening

What happens if I miss a dose (Arimidex)?

   Take the missed dose as soon as you remember. Skip the missed dose if
   it is almost time for your next scheduled dose. Do not take extra
   medicine to make up the missed dose.

What happens if I overdose (Arimidex)?

   Seek emergency medical attention or call the Poison Help line at
   1-800-222-1222.

What should I avoid while taking anastrozole (Arimidex)?

   This medicine can pass into body fluids (urine, feces, vomit).
   Caregivers should wear rubber gloves while cleaning up a patient's body
   fluids, handling contaminated trash or laundry or changing diapers.
   Wash hands before and after removing gloves. Wash soiled clothing and
   linens separately from other laundry.

   This medication may impair your thinking or reactions. Be careful if
   you drive or do anything that requires you to be alert.

What other drugs will affect anastrozole (Arimidex)?

   Anastrozole may not work as well if you take it together with an
   estrogen medication (such as hormone replacement therapy, estrogen
   creams, or birth control pills, injections, implants, skin patches, and
   vaginal rings). Before you start taking anastrozole, tell your doctor
   if you also take tamoxifen or estrogen.

   Other drugs may interact with anastrozole, including prescription and
   over-the-counter medicines, vitamins, and herbal products. Tell each of
   your health care providers about all medicines you use now and any
   medicine you start or stop using.

Where can I get more information (Arimidex)?

   Your pharmacist can provide more information about anastrozole.
     __________________________________________________________________


Комментарии

Популярные сообщения из этого блога

A healthy diet may trigger a better response to a certain kind of melanoma treatment. How?

New research suggests that a diet that's full of fiber appears to lead to more diverse intestinal bacteria (microbiome). In turn, a thriving gut microbiome is linked to a stronger response to an immune therapy for the aggressive skin cancer. "We found that patients eating a high-fiber diet at the start of therapy were about five times more likely to respond to the anti-PD-1 immunotherapy," said study author Christine Spencer. She's a research scientist with the Parker Institute for Cancer Immunotherapy in San Francisco. Anti-PD-1 immunotherapy helps the immune system recognize cancer cells as dangerous cells that need to be destroyed, according to the American Cancer Society (ACS). The cancer drugs Keytruda and Opdivo are examples of this type of immunotherapy. Melanoma is a type of skin cancer. It only accounts for about 1 percent of all skin cancers, but is responsible for most skin cancer deaths, the ACS says. Several recent studies have suggested that a ...

American Heart Association News

On Feb. 1, 1961, twins Debbie and Donna Horst arrived at the White House to fanfare. The 6-year-olds, decked out in fancy dresses and satin sashes, found themselves surrounded by a pressing crowd and a sea of blinding flashbulbs as they made their way to see Jacqueline Kennedy. The girls -- both born with holes in their aortas -- were meeting with the first lady to kick off a national campaign to raise awareness about congenital heart defects. "There were hundreds of reporters because this was Jacqueline Kennedy' first public act as first lady," Debbie said. She recalls being startled when the reporters asked Mrs. Kennedy if they could move in closer. "It was frightening because they all jumped at us at once." The Pennsylvania twins, just a few weeks from turning 7, were among the first "Heart Fund Sweethearts" in the campaign to raise money as well as awareness. The month before, they'd met up with Micki and Patricia Gane, also of Pennsylvania...

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its lead product candidate, Twirla®, an investigational low-dose combined hormonal contraceptive patch (AG200-15).  Agile resubmitted the NDA in response to a December 2017 Complete Response Letter (CRL) from the FDA, which identified deficiencies relating to (i) quality control adhesion test methods for the Twirla manufacturing process, (ii) observations identified during an inspection of a facility of our third-party manufacturer for the Twirla NDA that must be resolved, and (iii) questions on the in vivo adhesion properties of Twirla and their potential relationship to the SECURE clinical trial results. The resubmitted NDA includes the results from a...